# Investigations of the Pathophysiology of Gilles de la Tourette Syndrome. Part 2: 7T MRI

> **NCT05233306** · — · COMPLETED · sponsor: **Max Planck Institute for Human Cognitive and Brain Sciences** · enrollment: 65 (actual)

## Conditions studied

- Gilles de la Tourette Syndrome
- Tourette Syndrome

## Interventions

- **DEVICE:** MRI scanner (7 Tesla)

## Key facts

- **NCT ID:** NCT05233306
- **Lead sponsor:** Max Planck Institute for Human Cognitive and Brain Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-27
- **Primary completion:** 2023-04-06
- **Final completion:** 2023-07-07
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2024-03-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05233306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05233306, "Investigations of the Pathophysiology of Gilles de la Tourette Syndrome. Part 2: 7T MRI". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05233306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*